Time Studies Sample Clauses

Time Studies. The Union will be given access to the plant in order to perform time studies. The time and date of the time study must be mutually agreed by the Union and the Company.
View SourceView Similar (2)
Time Studies. An employee scheduled to be time studied during a given shift will be notified of the company's intention to make the study at least one-half (1/2) hour prior to the end of his preceding shift. The company will not be forced to advise employee in such a case as:
View SourceView Similar (2)
Time Studies. 1. The Company agrees to establish courses in time study techniques in order to train Union personnel. No more than two (2) employees will be trained at any one time. The Union will submit the names of the designated employees to the Company. 2. Time lost attending these courses by such employees shall be paid for by the Company at their classified rate. While attending these courses, such employees will be under the supervision of the Control Department. 3. The Union Time Study man shall be provided with or have access to the records (copies) of the Time Study Department. Other than if it be absolutely necessary in the processing of a grievance, the Time Study information and records furnished to the Union Time Study Representative by the Company cannot be removed from the Company premises. In the event that it is deemed necessary in the processing of a grievance to take such records off the premises, the Union Time Study Representative must sign a receipt for such written information and records that he requests to remove from the Company premises. In no event will the records or information being made available to the Union Time Study Representative be passed on to Company competitors. 4. The Union Time Study man will be assigned to regularly work the first shift during the Monday through Friday workweek on a job for which he is qualified. 5. The Union Time Study man and the alternate shall not be subject to the layoff provision of the contract, in effect they will have super-seniority (only to be exceeded by that of the Shop Committee), but shall be subject to all other provisions of the contract.
View SourceView Similar (2)
Time Studies. General Motors shall not use time studies to cause harm to this Union or its members. General Motors utilizes and recognizes GMS as playing a vital role in the operational efficiency and continuous improvement. Design Center Management utilizes such elements to assist with workload modeling, fabricating and the planning process. Therefore, it is not the intent to use such tools and data for the sole purpose of conducting time studies and/or direct indicator(s) of individual performance. (Deferred Holidays) All bargaining unit employees who work holidays, can either 1) be paid double time plus holiday pay or
View SourceView Similar (2)
Time Studies. 11 20.4.1 CONTRACTOR shall adhere to COUNTY time study 12 procedures by identifying and reporting time devoted to the delivery of 13 services pursuant to this Agreement. 14 20.4.2 Time studies must be completed by CONTRACTOR’s staff 15 in the months of February, May, August and November of each year. Completed 16 time studies shall be made available to ADMINISTRATOR by the first business 17 day of the month following each month in which the time study is to be 18 completed. 19 20.4.3 Supervisory staff do not complete detailed time study 20 form sheets, but must record the total hours worked per day in a time study 21 month. CONTRACTOR’s supervisors shall review the staff time study detail 22 report for accuracy and ensure consistency with reported work hours for the 23 same period.
View Source
Time Studies. (A) The Contractor agrees to conduct quarterly time/cost studies as required by the Department, in a Department approved format. (B) The Contractor shall maintain all records for services rendered under this Contract for a period of 5 years after the date of payment.
View Source
Time Studies. 22 20.4.1 CONTRACTOR shall adhere to COUNTY time study procedures by 23 identifying and reporting time devoted to the delivery of services pursuant to 24 this Agreement. 25 20.4.2 Time studies must be completed by CONTRACTOR’s staff in 26 the months of February, May, August and November of each year. Completed time 27 studies shall be made available to ADMINISTRATOR by the first business day of 28 the month following each month in which the time study is to be completed.
View Source
Time Studies. WTW 5 20.4.1 CONTRACTOR shall adhere to COUNTY time study procedures by WTW pursuant to this Agreement 6 identifying and reporting time devoted to the delivery of
View Source

Related to Time Studies

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus, or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMA, Health Canada and other comparable regulatory agencies outside of the U.S. to which they are subject, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312, and 812; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.